Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2018

Open Access 01.12.2018 | Research article

Combined perventricular closure of ventricular septal defect and atrial septal defect via lower ministernotomy

verfasst von: Yunfei Ling, Yue Wang, Qiang Fan, Yongjun Qian

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2018

Abstract

Background

Minimally invasive approaches such as perventricular closure of ventricular septal defects (VSD) have been applied for the surgical correction of congenital heart defects in order to avoid disadvantages related to median sternotomy with a cardiopulmonary bypass (CPB). However, reports remain scarce regarding combined perventricular closure of VSD and atrial septal defects (ASD) via minimally invasive approaches, such as lower ministernotomy.

Results

The authors have operated on 5 patients who were diagnosed with VSD in association with ASD, successfully realizing perventricular closure via lower ministernotomy.

Conclusion

The proposed technique proved to be safe and effective.
Abkürzungen
ASD
Atrial septal defect
CPB
Cardiopulmonary bypass
TEE
Transesophageal echocardiography
VSD
Ventricular septal defect

Background

Ventricular septal defects (VSD) are some of the most frequent congenital heart anomalies, estimated to account for 20–30% of all congenital cardiac malformations [1, 2]. In the last decade, perventricular approaches have been successfully applied for the closure of various types of VSD, with promising preliminary results [35]. However, to date, no reports are available regarding the combined perventricular closure of VSD and atrial septal defects (ASD) via minimally invasive approaches, such as lower ministernotomy.

Methods

We studied five patients (two boys and three girls) diagnosed with VSD and ASD who underwent operation at the West China Hospital. Answer: We have added the content as follow in the manuscript: All the patients were perimembranous VSD less than 8 mm that was not adjacent to the conduction bundle and aortic valves and the secundum ASD less than 15 mm. Table 1 presents the baseline data of patients.
Table 1
Baseline data of patients
Patient NO
Age (month)
Weight (kg)
VSD (mm)
ASD (mm)
VSD occluder (mm)
ASD occluder (mm)
1
19
12
4
6
6
12
2
14
10
5
5
7
12
3
26
13
6
8
8
14
4
18
12.
5
7
7
14
5
20
12
4
10
7
16
VSD ventricular septal defect, ASD atrial septal defect
After adequate pre-oxygenation, the procedure was performed under general anaesthesia with a standby cardiopulmonary bypass (CPB) machine available. Following a skin incision of approximately 4–5 cm, a partial lower ministernotomy was performed. After surgical exposure of the anterior free wall of the right ventricle, the optimal puncture site was selected per the routine method. Next, we performed perventricular VSD closure under transoesophageal echocardiographic (TEE) guidance using SQFDQ II and SQFDQ IV occlusion devices (MemoPart VSD Occlusion Device; Lepu Medical Technology, Shanghai Shape Memory Alloy Co., Ltd., Shanghai, China) (Fig. 1a), as described in previous reports [68]. Then, a 20 G needle was introduced into the right ventricle, and directed up towards the ASD. Then, a 0.025-in. straight-tipped guide wire was introduced through the needle and maneuvered across the tricuspid valve and ASD into the left atrium. Next, the needle was exchanged with a short 12 F sheath over the wire (Fig. 1b). Finally, the sheath was positioned across the ASD with its tip in the left atrium, and the ASD occluder was placed (MemoPart ASD Occlusion Device; Lepu Medical Technology, Shanghai Shape Memory Alloy Co., Ltd., Shanghai, China) (Fig. 1c).

Results

Surgery was successful in all patients, with no in-hospital mortality or complications. Mean ‘skin-to-skin’ time was 62 ± 31.6 min. No blood infusions or inotropic support were needed in any patient. Mean ventilation support time was 4.2 ± 6.7 h. No rhythm or atrioventricular conduction disorders occurred. No sternal or rib deformations were observed at the time of discharge, and the small skin incision yielded excellent cosmetic results. Mean hospitalization time was 6.5 ± 2.8 days.

Discussion

Conventionally, most congenital heart defects are treated using CPB via median sternotomy. With the development of percutaneous interventional techniques, various simple congenital structural heart defects may be repaired with comparable results, possibly providing advantages over conventional surgery in some cases [9]. However, transcatheter shunt closure does not appear to be optimal when the patients present other congenital heart diseases. This new technique should be applied with caution in some subtypes of VSDs like perimembranous VSDs adjacent to the conduction bundle and aortic valves and subarterial VSDs, We did not recommend the eccentric occluder device in the perimembranous VSDs; When the ASDs are too small, the angle through the fourth intercostal space to the ASDs will be hard, another left fourth intercostal space will be recommended to close the ASDs. With improvements in device closure techniques, perventricular device closure of VSD under guidance of transesophageal echocardiography (TEE) has been successfully applied in the surgical correction of congenital defects, with promising preliminary results [4]. Based on this technique, we proposed a new approach for combined perventricular closure of VSD and ASD via lower ministernotomy.

Conclusions

Compared with conventional surgical repair or femoral transcatheter shunt closure, the advantages of this procedure are obvious. It appears to be safe, associated with less operative trauma, and does not require CPB, fluoroscopy or contrast. In selected patients, perventricular device closure of VSD complicated with ASD is effective, and may either substitute or complement conventional surgical closure.

Acknowledgements

Not applicable

Funding

The study was supported by the Major Science and Technology Project of Sichuan Province, China (No. 2017SZ0056) and the Scientific Research Project of Sichuan Health and Family Planning Commission, China (No. 17PJ177).

Availability of data and materials

Datasets used or analysed during the current study are available from the corresponding author on reasonable request.
Not applicable
The relevant patient provided informed consent for publication of the images in Fig. 1.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation. 1971;43(3):323–32.CrossRef Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation. 1971;43(3):323–32.CrossRef
2.
Zurück zum Zitat Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of Perimembranous ventricular septal defects in children : a randomized controlled trial. J Am Coll Cardiol. 2014;63(12):1159–68.CrossRef Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of Perimembranous ventricular septal defects in children : a randomized controlled trial. J Am Coll Cardiol. 2014;63(12):1159–68.CrossRef
3.
Zurück zum Zitat Bacha EA, Cao QL, Starr JP, et al. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg. 2003;126(6):1718–23.CrossRef Bacha EA, Cao QL, Starr JP, et al. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg. 2003;126(6):1718–23.CrossRef
4.
Zurück zum Zitat Gan C, An Q, Lin K, et al. Perventricular device closure of ventricular septal defects: six months results in 30 young children. Ann Thorac Surg. 2008;86(1):142–6.CrossRef Gan C, An Q, Lin K, et al. Perventricular device closure of ventricular septal defects: six months results in 30 young children. Ann Thorac Surg. 2008;86(1):142–6.CrossRef
5.
Zurück zum Zitat Thakkar B, Patel N, Shah S, et al. Perventricular device closure of isolated muscular ventricular septal defect in infants: a single Centre experience. Indian Heart J. 2012;64(6):559–67.CrossRef Thakkar B, Patel N, Shah S, et al. Perventricular device closure of isolated muscular ventricular septal defect in infants: a single Centre experience. Indian Heart J. 2012;64(6):559–67.CrossRef
6.
Zurück zum Zitat Voitov A, Omelchenko A, Gorbatykh Y, Zaitsev G, Arkhipov A, Soynov I, et al. Outcomes of perventricular off-pump versus conventional closure of ventricular septal defects: a prospective randomized study. Eur J Cardiothorac Surg. 2017;51:980–6.CrossRef Voitov A, Omelchenko A, Gorbatykh Y, Zaitsev G, Arkhipov A, Soynov I, et al. Outcomes of perventricular off-pump versus conventional closure of ventricular septal defects: a prospective randomized study. Eur J Cardiothorac Surg. 2017;51:980–6.CrossRef
7.
Zurück zum Zitat Omelchenko A, Gorbatykh Y, Voitov A, Zaitsev G, Bogachev-Prokophiev A, Karaskov A. Perventricular device closure of ventricular septal defects: results in patients less than 1 year of age. Interact Cardiovasc Thorac Surg. 2016;22:53–6.CrossRef Omelchenko A, Gorbatykh Y, Voitov A, Zaitsev G, Bogachev-Prokophiev A, Karaskov A. Perventricular device closure of ventricular septal defects: results in patients less than 1 year of age. Interact Cardiovasc Thorac Surg. 2016;22:53–6.CrossRef
9.
Zurück zum Zitat Mavroudis C, Backer CL. Pediatric cardiac surgery. 4th ed. UK: Wiley Blackwell; 2013. p. 311–41.CrossRef Mavroudis C, Backer CL. Pediatric cardiac surgery. 4th ed. UK: Wiley Blackwell; 2013. p. 311–41.CrossRef
Metadaten
Titel
Combined perventricular closure of ventricular septal defect and atrial septal defect via lower ministernotomy
verfasst von
Yunfei Ling
Yue Wang
Qiang Fan
Yongjun Qian
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2018
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-018-0815-5

Weitere Artikel der Ausgabe 1/2018

Journal of Cardiothoracic Surgery 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.